Trending Topics


Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator

The 2016 ASTRO Annual Meeting will take place in Boston from September 25 to 28. Featuring new insights and discoveries from leading institutions around the world, this scientific forum will include presentations and data that could affect the way cancer care is planned and delivered. Memorial Sloan Kettering radiation oncologists are available to comment on meeting news and presentations. Follow the meeting live on Twitter using the hashtag #ASTRO16. For more information or to speak with an expert, contact
Friday, September 23, 2016
A new drug is being shown to extend the lives of patients with advanced soft tissue sarcoma by almost a year. The results of a multicenter phase II trial evaluating the efficacy and safety of olaratumab in combination with doxorubicin chemotherapy was published in The Lancet on June 9. William Tap, MD, Chief of the Sarcoma Medical Oncology Service at Memorial Sloan Kettering Cancer Center (MSK), served as corresponding author on this study, which met its primary endpoint of progression-free survival and showed a statistically significant improvement in overall survival. To arrange an interview with Dr. Tap, please email
Friday, June 10, 2016
MSK researchers are presenting nearly 120 studies at the 2016 Annual Meeting of the American Society of Clinical Oncology.
Friday, June 3, 2016
See all trending topics

Press Releases

When Memorial Sloan Kettering Cancer Center (MSK) opened its doors along Commack Road in 2002, eastern Long Islanders no longer needed to navigate congested roadways and train lines bound for Manhattan to receive personalized cancer care. Today, more than 14 years later, MSK is reinforcing its commitment to the local community in the form of a 38,000-plus-square-foot addition complete with enhancements to both clinical programs and physical spaces.
Monday, October 17, 2016
Molecular biologist Christine Mayr, MD, PhD, of Memorial Sloan Kettering’s (MSK) Sloan Kettering Institute (SKI) is one of 12 2016 recipients of the prestigious National Institutes of Health (NIH) Director’s Pioneer Award. Established in 2004, the annual award recognizes and supports individual scientists of exceptional creativity who propose pioneering and highly innovative approaches with the potential to produce an unusually high impact on biomedical or behavioral research.
Tuesday, October 4, 2016
There has been much recent excitement about immunotherapy and the use of genetically engineered chimeric antigen receptor (CAR) T cells. Historically, CAR T cell immunotherapy has aimed to boost the immune system by giving immune cells the information they need to better recognize tumor cells as foreign and attack them. New work led by Hans-Guido Wendel, MD, of Memorial Sloan Kettering Cancer Center (MSK), and collaborator Karin Tarte of the University of Rennes, France, illustrates an untapped potential of CAR T cells to act as targeted delivery vehicles that can function as “micro-pharmacies” for precise therapeutic delivery.
Thursday, September 29, 2016
See all press releases

On Our Blog

It can be hard to understand all the various radiation therapy options for prostate cancer. Here, we explain.
Tuesday, October 25, 2016
Learn about different medications cancer patients can take to cope with depression and anxiety.
Thursday, October 20, 2016
After a string of failures, therapeutic cancer vaccines have acquired something of a bad rap. Can we do better?
Wednesday, October 19, 2016
See all blog posts

Media Coverage

Medical oncologist Andrew Epstein was interviewed about pain and palliative care in HealthDay News. 
Wednesday, September 21, 2016
MSK’s Teen and Young Adult Program, TYA@MSK, is featured in The Huffington Post. 
Sunday, September 18, 2016
Medical oncologist Jacqueline Bromberg discusses inflammatory breast cancer with The Huffington Post
Sunday, September 18, 2016
See all media coverage

If you wish to contact MSK about a marketing or advertising related opportunity, or are looking for additional information about our ad campaign, please email us at

For Journalists

Jeanne D'Agostino
Director, Media and Public Relations
Emily O'Donnell
Senior Communications Associate, Department of Surgery
Courtney Nowak
Senior Media Relations Associate
Caitlin Hool
Senior Media Associate
Nicole H. McNamara
Senior Media Relations Associate
Rebecca Williams
Media Associate
For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.
After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.

Subscribe to the News@MSKCC newsletter

Our email newsletter for journalists offers the latest advances in cancer research and treatment, including story ideas, institutional milestones and plans, and newsworthy staff accomplishments.

Sign up

Unsubscribe »